Literature DB >> 16039000

Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein.

Ritu R Bradley1, Masanori Terajima.   

Abstract

The K1L protein of vaccinia virus is required for its growth in certain cell lines (RK-13 and human). The cowpox host-range protein CP77 has been shown to complement K1L function in RK-13 cells, despite a lack of homology between the two proteins except for ankyrin repeats. We investigated the role of ankyrin repeats of K1L protein in RK-13 cells. The growth of a recombinant vaccinia virus, with K1L gene mutated in the most conserved ankyrin repeat, was severely impaired. Infection with the mutant virus caused shutdown of cellular and viral protein synthesis early in infection. We also investigated the interaction of K1L protein with cellular proteins and found that K1L interacts with the rabbit homologue of human ACAP2, a GTPase-activating protein with ankyrin repeats. Our result suggests the importance of ankyrin repeat for host-range function of K1L in RK-13 cells and identifies ACAP2 as a cellular protein, which may be interacting with K1L.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039000     DOI: 10.1016/j.virusres.2005.06.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

2.  Antigen presentation assays to investigate uncharacterized immunoregulatory genes.

Authors:  Rachel L Roper
Journal:  Methods Mol Biol       Date:  2012

3.  Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.

Authors:  Liang Deng; Peihong Dai; Wanhong Ding; Richard D Granstein; Stewart Shuman
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Structure function studies of vaccinia virus host range protein k1 reveal a novel functional surface for ankyrin repeat proteins.

Authors:  Yongchao Li; Xiangzhi Meng; Yan Xiang; Junpeng Deng
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

5.  MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.

Authors:  Sophie Blanié; Jacqueline Gelfi; Stéphane Bertagnoli; Christelle Camus-Bouclainville
Journal:  Virol J       Date:  2010-03-08       Impact factor: 4.099

6.  Orf virus (ORFV) ANK-1 protein mitochondrial localization is mediated by ankyrin repeat motifs.

Authors:  Krzysztof Lacek; Berthilde Bauer; Krystyna Bieńkowska-Szewczyk; Hanns-Joachim Rziha
Journal:  Virus Genes       Date:  2014-04-18       Impact factor: 2.332

7.  Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex.

Authors:  Nick van Buuren; Brianne Couturier; Yue Xiong; Michele Barry
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

8.  The effect of the vaccinia K1 protein on the PKR-eIF2alpha pathway in RK13 and HeLa cells.

Authors:  Kristen L Willis; Samir Patel; Yan Xiang; Joanna L Shisler
Journal:  Virology       Date:  2009-09-09       Impact factor: 3.616

9.  Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.

Authors:  Gilad Sivan; Shira G Glushakow-Smith; George C Katsafanas; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

10.  M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit.

Authors:  Sophie Blanié; Jérémy Mortier; Maxence Delverdier; Stéphane Bertagnoli; Christelle Camus-Bouclainville
Journal:  Vet Res       Date:  2008-11-19       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.